WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Zilucoplan is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.

There is limited information regarding Zilucoplan FDA-Labeled Indications and Dosage (Adult) in the drug label.

There is limited information regarding Zilucoplan FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

There is limited information regarding Zilucoplan Contraindications in the drug label.

There is limited information regarding Zilucoplan Warnings’ in the drug label.

There is limited information regarding Zilucoplan Clinical Trials Experience in the drug label.

There is limited information regarding Zilucoplan Postmarketing Experience in the drug label.

There is limited information regarding Zilucoplan Drug Interactions in the drug label.

Pregnancy Category (FDA): There is no FDA guidance on usage of Zilucoplan in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Zilucoplan in women who are pregnant.

There is no FDA guidance on use of Zilucoplan during labor and delivery.

There is no FDA guidance on the use of Zilucoplan in women who are nursing.

There is no FDA guidance on the use of Zilucoplan in pediatric settings.

There is no FDA guidance on the use of Zilucoplan in geriatric settings.

There is no FDA guidance on the use of Zilucoplan with respect to specific gender populations.

There is no FDA guidance on the use of Zilucoplan with respect to specific racial populations.

There is no FDA guidance on the use of Zilucoplan in patients with renal impairment.

There is no FDA guidance on the use of Zilucoplan in patients with hepatic impairment.

There is no FDA guidance on the use of Zilucoplan in women of reproductive potentials and males.

There is no FDA guidance one the use of Zilucoplan in patients who are immunocompromised.

There is limited information regarding Zilucoplan Administration in the drug label.

There is limited information regarding Zilucoplan Monitoring in the drug label.

There is limited information regarding the compatibility of Zilucoplan and IV administrations.

There is limited information regarding Zilucoplan overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

There is limited information regarding Zilucoplan Pharmacology in the drug label.

There is limited information regarding Zilucoplan Mechanism of Action in the drug label.

There is limited information regarding Zilucoplan Structure in the drug label.

There is limited information regarding Zilucoplan Pharmacodynamics in the drug label.

There is limited information regarding Zilucoplan Pharmacokinetics in the drug label.

There is limited information regarding Zilucoplan Nonclinical Toxicology in the drug label.

There is limited information regarding Zilucoplan Clinical Studies in the drug label.

There is limited information regarding Zilucoplan How Supplied in the drug label.

There is limited information regarding Zilucoplan Storage in the drug label.

There is limited information regarding Zilucoplan Patient Counseling Information in the drug label.

Alcohol-Zilucoplan interaction has not been established. Talk to your doctor regarding the effects of taking alcohol with this medication.

There is limited information regarding Zilucoplan Brand Names in the drug label.

There is limited information regarding Zilucoplan Look-Alike Drug Names in the drug label.

The contents of this FDA label are provided by the National Library of Medicine.